Assay Detail
Binding
CHEMBL1771845
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of human ERG
12
Total Activities
8
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Target
Voltage-gated inwardly rectifying potassium channel KCNH2 (CHEMBL240) ↗| Type | SINGLE PROTEIN |
| Organism | Homo sapiens |
Publication
Design of potent and selective GPR119 agonists for type II diabetes.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 12 | 5.70 | 6.56 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL1771093 | — | — | 1 | 6.56 |
| CHEMBL1771099 | — | — | 2 | 5.92 |
| CHEMBL1771097 | — | — | 2 | 5.82 |
| CHEMBL1771094 | — | — | 1 | 5.75 |
| CHEMBL1771098 | — | — | 3 | 5.58 |
| CHEMBL1771095 | — | — | 1 | 5.27 |
| CHEMBL1771096 | — | — | 1 | 4.97 |
| CHEMBL1771104 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL1771093 | — | IC50 | = | 277.0 | nM | 6.56 |
| CHEMBL1771099 | — | IC50 | = | 1200.0 | nM | 5.92 |
| CHEMBL1771097 | — | IC50 | = | 1500.0 | nM | 5.82 |
| CHEMBL1771094 | — | IC50 | = | 1800.0 | nM | 5.75 |
| CHEMBL1771097 | — | IC50 | = | 1900.0 | nM | 5.72 |
| CHEMBL1771098 | — | IC50 | = | 2600.0 | nM | 5.58 |
| CHEMBL1771095 | — | IC50 | = | 5400.0 | nM | 5.27 |
| CHEMBL1771096 | — | IC50 | = | 10600.0 | nM | 4.97 |
| CHEMBL1771098 | — | IC50 | > | 30000.0 | nM | - |
| CHEMBL1771098 | — | IC50 | > | 30000.0 | nM | - |
| CHEMBL1771099 | — | IC50 | > | 30000.0 | nM | - |
| CHEMBL1771104 | — | IC50 | > | 30000.0 | nM | - |